IN DEPTH

Unpacking the complex challenge of biologics

Living medicines: using bacteria to fight cancer

Inside the marred history of HIV vaccine trials

Supply chain

Securing the US API supply

Covid-19 has exposed key weaknesses in the US's active pharmaceutical ingredient supply chain

PHARMACOVIGILANCE

Pushing pharmacovigilance to innovate post pandemic

Q&A: covid-19

Could Winter the llama hold the key to treating Covid-19?

Unpacking the complex challenge of biologics

Living medicines: using bacteria to fight cancer

Inside the marred history of HIV vaccine trials

02/24/2024 14:38:21
  • Home | Unpacking innovation in biologics 
  • In this issue
  • Contents
  • Myonex
  • Controlant Company Insight
  • Controlant
  • SHL Medical
  • Labcorp
  • Reuters
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mimotopes Company Insight
  • Mimotopes
  • TQS Integration Company Insight
  • TQS Intergration
  • Biesterfeld
  • Comment
  • Biotech and China: a global opportunity
  • Intranasal ketamine could effectively treat phantom pain
  • EU biosimilar wave slows as biosimilar approvals decrease in the EU
  • Biosynth Carbosynth Company Insight
  • Biosynth Carbosynth
  • Molnár-Institute Company Insight
  • Molnar-Institute
  • Skyepharma
  • In Depth
  • Unpacking the complex challenge of biologics
  • Living medicines: using bacteria to fight cancer
  • The marred history of HIV vaccine trials
  • Has Covid-19 exposed the weakness of the US pharma supply chain?
  • How the pandemic pushed pharmacovigilance to innovate
  • ExeVir: the llama-derived antibody that could fight Covid-19
  • BEA Technologies
  • Watlow
  • Duoject
  • Butterworth
  • In Data
  • Data: Big Data hiring efforts in pharma
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
09/23/2021 00:00:00